Dérivé promédicament aminoacylé et médicament pour le traitement de maladies thromboemboliques

Aminoacyl-prodrug derivate und arzneimittel zur behandlung von thromboembolischen erkrankungen

Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders

Abstract

The present application relates to prodrug derivatives of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-l,3-oxazolidine-5-yl}methyl)thiophene-2-carboxamide, to processes for their preparation, to their use for treatment and/or prophylaxis of diseases and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, especially of thromboembolic disorders.
Die vorliegende Anmeldung betrifft Prodrug-Derivate von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-l,3-oxazolidin-5-yl}methyl)thiophen-2-carboxamid, Verfahren zu ihrer Herstellung, ihre Verwendung zur Behandlung und/oder Prophylaxe von Krankheiten sowie ihre Verwendung zur Herstellung von Arzneimitteln zur Behandlung und/oder Prophylaxe von Krankheiten, insbesondere von thromboembolischen Erkrankungen.
La présente invention concerne des dérivés promédicaments de 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phényl]-1,3-oxazolidin-5-yl}méthyl)thiophène-2-carboxamide, des procédés pour les préparer, leur utilisation pour le traitement et/ou la prévention de maladies ainsi que leur utilisation dans la préparation de médicaments destinés au traitement et/ou à la prévention de maladies, en particulier de maladies thromboemboliques.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (2)

    Publication numberPublication dateAssigneeTitle
    WO-0100622-A1January 04, 2001Vertex Pharmaceuticals IncorporatedPromedicaments a base d'inhibiteurs carbamates de l'impdh
    WO-2005028473-A1March 31, 2005Pharmacia & Upjohn Company LlcBioprecurseurs acyloxymethylcarbamate des oxazolidinones

NO-Patent Citations (3)

    Title
    KAHNS A H ET AL: "N ACYL DERIVATIVES AS PRODRUG FORMS FOR AMIDES CHEMICAL STABILITY AND ENZYMATIC HYDROLYSIS OF VARIOUS N ACYL AND N ALKOXYCARBONYL AMIDE DERIVATIVES" INTERNATIONAL JOURNAL OF PHARMACEUTICS (KIDLINGTON), Bd. 71, Nr. 1-2, 1991, Seiten 31-44, XP002440260 ISSN: 0378-5173
    None
    ROEHRIG S ET AL: "Discovery of the Novel Antithrombotic Agent 5-Chloro-N-(((5S)-2-oxo-3 [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazol idin-5-yl)methyl)thiophene 2-carboxamide (BAY 59-7939): An Oral, Direct Factor Xa Inhibitor" JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, Bd. 48, 22. September 2005 (2005-09-22), Seiten 5900-5908, XP002418821 ISSN: 0022-2623 in der Anmeldung erwähnt

Cited By (3)

    Publication numberPublication dateAssigneeTitle
    JP-2009526788-AJuly 23, 2009バイエル・ヘルスケア・アクチェンゲゼルシャフトBayer HealthCare AG血栓塞栓性障害の処置用のアミノアシルプロドラッグ誘導体および医薬
    US-7816355-B1October 19, 2010Apotex Pharmachem IncProcesses for the preparation of rivaroxaban and intermediates thereof
    US-8101609-B2January 24, 2012Apotex Pharmachem Inc.Processes for the preparation of rivaroxaban and intermediates thereof